View in EDS

Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.

Saved in:
Bibliographic Details
Title: Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
Authors: Brudno JN; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Natrakul DA; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Karrs J; Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Patel N; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Maass-Moreno R; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD., Ahlman MA; Department of Radiology and Imaging, Medical College of Georgia, Augusta, GA., Mikkilineni L; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Mann J; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Stroncek DF; Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, MD., Highfill SL; Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, MD., Fromm GC; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Patel R; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Pittaluga S; Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Kochenderfer JN; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Source: Blood advances [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 802-814.
Publication Type: Clinical Trial, Phase I; Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37939262
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brudno+JN%22">Brudno JN</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Natrakul+DA%22">Natrakul DA</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Karrs+J%22">Karrs J</searchLink>; Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Patel+N%22">Patel N</searchLink>; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Maass-Moreno+R%22">Maass-Moreno R</searchLink>; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Ahlman+MA%22">Ahlman MA</searchLink>; Department of Radiology and Imaging, Medical College of Georgia, Augusta, GA.<br /><searchLink fieldCode="AU" term="%22Mikkilineni+L%22">Mikkilineni L</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Mann+J%22">Mann J</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Stroncek+DF%22">Stroncek DF</searchLink>; Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Highfill+SL%22">Highfill SL</searchLink>; Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Fromm+GC%22">Fromm GC</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Patel+R%22">Patel R</searchLink>; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Pittaluga+S%22">Pittaluga S</searchLink>; Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Kochenderfer+JN%22">Kochenderfer JN</searchLink>; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 802-814.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37939262
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2023011470
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 802
    Titles:
      – TitleFull: Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brudno JN
      – PersonEntity:
          Name:
            NameFull: Natrakul DA
      – PersonEntity:
          Name:
            NameFull: Karrs J
      – PersonEntity:
          Name:
            NameFull: Patel N
      – PersonEntity:
          Name:
            NameFull: Maass-Moreno R
      – PersonEntity:
          Name:
            NameFull: Ahlman MA
      – PersonEntity:
          Name:
            NameFull: Mikkilineni L
      – PersonEntity:
          Name:
            NameFull: Mann J
      – PersonEntity:
          Name:
            NameFull: Stroncek DF
      – PersonEntity:
          Name:
            NameFull: Highfill SL
      – PersonEntity:
          Name:
            NameFull: Fromm GC
      – PersonEntity:
          Name:
            NameFull: Patel R
      – PersonEntity:
          Name:
            NameFull: Pittaluga S
      – PersonEntity:
          Name:
            NameFull: Kochenderfer JN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 02
              Text: 2024 Feb 13
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1